PPARG and obesity disorder: Although the expression of PPARα in adipose tissue is much lower compared to PPARγ, there is evidence that PPARα activation may reduce adipose tissue inflammation during obesity by decreasing adipocyte hypertrophy, by regulating inflammatory gene expression via locally expressed PPARα, and/or by systemic events likely originating from the liver [19].